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Intravaginal insertion is often associated with the concept of ‘dry’ sex. All HIV-
prevention microbicides tested to date have been vaginally applied lubricant-based
gels. In this paper, we examine whether the use of intravaginal insertions could be in
conflict with the introduction of vaginal microbicide gels. The Africa Centre site was
part of the Microbicides Development Programme evaluating PRO2000/5 microbicide
gel. We conducted in-depth-interviews and focus-group discussions with women
enrolled in the trial as well as women and men from the community. The analysis
focused on people’s knowledge of intravaginal insertion in the community and trial
participants’ experience of using trial gels. Intravaginal use of a variety of products was
widely acknowledged. We found that the experience of using trial gels – which made
sex ‘hot’, ‘tight’ and ‘dry’ – matched the desired outcomes of intravaginal insertion.
We found that vaginal ‘dryness’ described the removal of excessive amounts of
unusual discharge, rather than the removal of normal vaginal secretions and that
intravaginal insertion is not exclusively associated with a desire for ‘dry’ sex. Study
findings provide evidence that vaginal microbicide gels may be more acceptable in
communities where intravaginal insertion is practiced than was previously thought.
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Introduction
Microbicides are experimental products being evaluated to find out if they reduce the risk
of HIV infection for women during sexual intercourse. Seven microbicides have entered
clinical efficacy trials to date and all have been tested in a lubricant-based gel that women
insert vaginally prior to sex (http://dev.it-insights.com/avac/CandidateProducts.aspx).
Evidence predominantly from early-phase microbicide trials has demonstrated very high
levels of acceptability of gel use among women and men in sub-Saharan Africa (Bentley
et al. 2004; Montgomery et al. 2010; Morrow et al. 2003; Ramjee et al. 2007; Vandebosch
et al. 2004; Woodsong and Alleman 2008).
However, a number of authors have questioned whether microbicide gels will be
acceptable among women who engage in vaginal practices to achieve ‘dry’ sex (Bagnol and
Mariano 2008; Beksinska et al. 1999; Kun 1998; Scorgie et al. 2009). There is an extensive
body of literature on vaginal practices in Southern Africa (Bangol and Mariano 2008;
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Beksinska et al. 1999; Braunstein and van de Wijgert 2003; Brown, Ayowa and Brown
1993; Brown and Brown 2000, Civic and Wilson 1996; Dallabetta et al. 1995; Hilber et al.
2010; Runganga, Pitts and McMaster 1992; Sandala et al. 1995; Scorgie et al. 2009). This
literature is compatible with the findings of the World Health Organization (WHO) (2007)
multi-country study on gender, sexuality and vaginal practices, which identified six distinct
types of vaginal practices: (1) external washing with or without products, (2) external
application of products around the vulva, (3) anatomical modification, (4) intravaginal
cleansing with or without products, (5) intravaginal insertion of products and (6) oral
ingestion of specific foods (such as porridge) or poultices to alter the vaginal environment
(Hilber et al. 2007). A number of commercial products and herbal preparations are used for
these purposes. Five main reasons for vaginal practices have been identified in the literature
referenced above: (1) vaginal cleansing, (2) treatment of sexually transmitted infections
(STIs) or vaginal discharge, (3) prevention of pregnancy or to induce abortion,
(4) enhancment of sexual pleasure and (5) as a ‘love potion’ to attract or retain partners.
‘Dry’ sex can be achieved by oral ingestion, intravaginal cleansing, external application
and the intravaginal insertion of a variety of products (Brown, Ayowa and Brown 1993;
Sandala et al. 1995; Scorgie et al. 2009). The use of products to dry the vagina has
specifically been reported in relation to removing vaginal discharge and enhancing sexual
pleasure (Beksinska et al. 1999; Brown et al. 2000). However, the WHO study found that
practices to enhance sexual pleasure ‘are not always aimed at “drying” the vagina; women
focused more on “closing, warming and tightening”’ the vagina (http://www.who.int/
reproductivehealth/topics/fgm/other_harmful_practices/en/; also see Hilber et al. 2010). In
addition to ‘warming’ the vagina (Beksinska et al. 1999; Brown, Ayowa and Brown 1993;
Civic and Wilson 1996), references to vaginal practices making a woman ‘hot’ during sex,
in terms of being sexually aroused, have been noted in KwaZulu-Natal (Berglund 1976;
Morar and Ramjee 1997; Scorgie et al. 2009), Mozambique (Bagnol and Mariano 2008)
and Zimbabwe (Runganga, Pitts and McMaster 1992).
Research in KwaZulu-Natal has demonstrated that sex workers regularly use products
for intravaginal cleansing and intravaginal insertion (Karim et al. 1995; Morar and
Ramjee 1997; Morar, Ramjee and Karim 1998). More recently, a representative
population-level survey investigating vaginal practices in KwaZulu-Natal found that in
the previous month, approximately 50% of women reported intravaginal cleansing, 9%
external application, 13% intravaginal insertion and 13% oral ingestion (Beksinska et al.
2008). Qualitative research in KwaZulu-Natal has added to our understanding of the
factors that motivate women to engage in vaginal practices, which include women’s
desire to increase men’s sexual pleasure and maintain fidelity within their relationships
(Scorgie et al. 2009).
This paper specifically focuses on the use of intravaginal insertions to enhance sexual
pleasure for two reasons. Firstly, as microbicide gels are applied intravaginally they are
particularly comparable with intravaginal insertions. Secondly, the main challenge to the
acceptability of microbicides is in relation to the impact that a vaginal lubricant gel
may have on sexual pleasure, especially in relation to a desire for ‘dry’ sex. To better
understand whether a lubricant-based vaginal microbicide gel would be acceptable in
communities where intravaginal insertions are used, we investigated the desired effects of
intravaginal insertion. We then investigated how women experienced the use of vaginal
gels in a microbicide clinical trial in KwaZulu-Natal. We compared these findings to further
understand sexual practices, preferences and expectations.
This paper uses qualitative data from women in the Microbicides Development
Programme (MDP) clinical trial as well as women and men in the community where the
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trial was conducted. We examine whether the use of intravaginal insertions conflicts with
the introduction of microbicide gels in a rural part of KwaZulu-Natal, South Africa. This is
the first study to make this comparison.
Methods
The Africa Centre for Health and Population Studies is a predominantly rural research site
based in the Umkhanyakude District of KwaZulu-Natal, South Africa (Tanser et al. 2008;
http://www.africacentre.ac.za/). The Africa Centre was one of six research centres
conducting the MDP301 randomised, double-blind, placebo-controlled, phase III clinical
trial that evaluated the safety and efficacy of PRO2000/5 microbicide gel in the prevention
of vaginally-acquired HIV infection. The study design has been described elsewhere
(Nunn et al. 2009) and the results were released in December 2009 (http://www.mdp.mrc.
ac.uk/).
The trial at the Africa Centre commenced in March 2006 and enrolled 1177 HIV-
negative women by August 2008. HIV-negative women who agreed to participate were
randomly assigned to use 2% PRO2000/5, 0.5% PRO2000/5 or a placebo gel. Gel
allocation was blinded at the time of the analysis. Women were instructed to insert 2 ml
of gel vaginally prior to sex from a pre-filled applicator. They were counselled to use
condoms and not to use intravaginal insertions during the trial. Participants were recruited
from 3 of the 16 primary healthcare clinics in the Hlabisa health sub-district.
At enrolment approximately 8% of trial participants were randomly selected to
participate in up to three in-depth-interviews (IDIs) at 4, 24 and 52 weeks after enrolment,
20% of their male partners were also identified for interview. In addition, some trial
participants not selected for IDIs were invited to participate in focus-group discussions
(FGDs), as were women and men from the community not enrolled in the trial. Trial
participant and community FGDs were advertised in research clinics and at community
events, respectively, to attract volunteers on an ad-hoc basis. Volunteers were allocated to
FGDs stratified by sex, age and residency in rural or peri-urban areas. All participants
provided written informed consent. Pseudonyms are used in this paper to maintain
participants’ anonymity.
The interviews and FGDs followed a semi-structured interview guide and were
conducted by trained isiZulu-speaking research assistants. The IDIs and FGDs were
recorded, transcribed in isiZulu and translated into English. Approximately 5% of the
transcripts were re-transcribed, re-translated or back-translated for quality control.
Transcripts were coded thematically with predefined themes (Boyatzis 1998) and analysed
using the qualitative data analysis software NVivo 2. The coding themes were developed
following a review of the relevant literature, findings from formative research conducted
during earlier feasibility and pilot studies and by induction driven by the data. The analysis
was based on accounts of trial participants’ and their partners’ personal experience of using
trial gels, trial participants’ as well as community members’ knowledge of intravaginal
insertion in the community and, in a minority of cases, respondents’ personal experience
of using intravaginal insertions.
In total, data from 118 IDIs, with 63 women and 8 men, and 15 FGDs, with 73 women
and 53 men, are included in the analysis. The composition of the IDI sample is presented in
Table 1 and of the FGD sample in Table 2. Data saturation had been achieved in relation to
the topics of interest prior to the analysis. The study was approved by the Medicines
Control Council (N2/19/8/2) and the University of KwaZulu-Natal Biomedical Research
Ethics Committee (T111/05).
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Findings
Intravaginal insertion
In both the IDIs and FGDs women and men widely acknowledged the intravaginal use of a
variety of products. In their first interview, 47 of the 63 trial participants said they knew
that women in the community used intravaginal insertions. The majority of participants in
14 of the 15 FGDs were also familiar with the topic. Knowledge about the use of insertions
was based on rumours in the community, seeing products sold on the street, stories from
neighbours, friends or female family members using products and, occasionally, personal
experience. Respondents said that women used intravaginal insertions predominantly to
enhance sexual pleasure. Other reasons for using intravaginal insertions were reported but
are not included in this analysis, including cleaning the vagina, maintaining good health
and as a ‘love potion’ to attract or retain a sexual partner.
Of the 63 trial participants interviewed, only 7 reported ever using intravaginal
insertions themselves for sexual pleasure before joining the trial. None of the participants
reported use during the trial. Female community members not enrolled in the trial were not
asked directly about their own personal use of insertions because this information was
collected in FGDs, but a similar proportion spontaneously described using insertions
themselves. There was no age differentiation in women’s knowledge of product use. The
majority of all female and male respondents said this was an age-old practice as articulated
by Nozipho who had experience of selling and using intravaginal insertions:
We were using them [insertions] a long time ago, even our mothers were using them.
(Nozipho, 50-year-old female FGD participant)
Respondents said they were aware of a number of products that were used as
intravaginal insertions to increase sexual pleasure. These included a range of medications
and general personal hygiene products, such as Disprin (Asprin), Inza (Ibupofen), Colgate
Table 1. Description of the in-depth interview (IDI) sample.
Female participant IDIs Male partner IDIs
Week-4 63 8
Week-24 38*
Week-52 9*
Total number of IDIs 110 8
Number of respondents 63 8
Mean age 33 41
Age range 19–64 26–60
Notes: *The 38 women interviewed at week-24 and the 9 interviewed at week-52 were initially interviewed at
week-4.
Table 2. Description of the focus group discussion (FGD) sample.
Female
participant FGDs
Female
community FGDs
Male
community FGDs
Total number of FGDs 6 3 6
Number of respondents 47 26 53
Mean age 35 29 25
Age range 19–65 18–59 18–45
932 M. Gafos et al.
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toothpaste, Blue Stone (copper sulphate, used locally to clean wounds) and bath salts.
There were also commercial products such as snuff (crushed tobacco), alum (hydrated-
aluminium-potassium-sulphate) and Knorrox cubes (South African food seasoning), as
well as complementary medicines such as Tiger Balm (an anodyne and anti-itching remedy
used for colds, headaches or insect bites), Entressdruppels (an oral remedy to relieve
nervousness, restlessness and sleeplessness) and Staaldruppels (an oral treatment for iron
deficiency anaemias and stopping bleeding). Other general items infrequently reported to
be inserted vaginally included whisky, newspaper after being softened by rubbing, water
after boiling rice in it and water after soaking a type of jelly fish (also renowned for treating
asthma and arthritis when taken orally). There was a range of sexual stimulants that were
designed to be taken orally, but were sometimes inserted vaginally, such as Silver Bullets
(tablets crushed before insertion) and Love Drops (liquid). In addition there was a range of
traditional medicines (locally called muthi [singular] or mithi [plural]). Generally
respondents were unaware of the actual names or contents of the mithi, but some were
mentioned such as imbulu oil (oil and fat of a water monitor), ‘mamlambo’ snake oil,
hippopotamus fat and umganu tree bark (soaked and then water inserted vaginally). Overall,
the most commonly reported intravaginal insertions were snuff, alum and a range of mithi.
Intravaginal insertions were reportedly used in a variety of ways to enhance sexual
pleasure. Some products were diluted in water and then used for intravaginal cleansing
(particularly alum) or inserted and either left to ‘dissolve’ (e.g. Tiger Balm or Blue Stone)
or inserted and the remnants removed prior to sex (e.g. traditional herbs and snuff). There
were only two references to muthi for sexual pleasure being administered via razor cuts
made in the skin in the genital area (gcaba: a common way to administer traditional
medicine) (Henderson 2005; Jolles and Jolles 2000). Respondents reported that these
products were readily available from pharmacies, shops and traditional healers.
Many respondents referred to a state of sexual preparedness that a woman was expected
to achieve and this was most regularly described as a woman being ‘alright’ in advance of
sex. For example, Fundile said that women use intravaginal insertions:
. . . so that should her lover arrive he would find her in a good condition. (Fundile, 24-year-old
trial participant)
In order of reporting frequency, the desired outcome of using intravaginal insertions was to
make a woman ‘hot’, ‘tight’ or ‘dry’ during sex, these concepts are explored below.
Hot sex
Intravaginal insertions have previously been described as increasing the ‘warmth’ of the
vagina. However, in this study when respondents referred to using insertions to be ‘hot’
(shisa), only on a few occasions did this relate to the vagina itself being ‘hot’. Instead it
predominantly related to sexual arousal. Similarly references to a woman being ‘cold’
(banda or qanda) related to women not being sexually attractive, not being aroused or being
sexually unresponsive. When asked to define the difference between ‘hot’ and ‘cold’ sex,
one participant explained that if sex was not hot ‘I don’t care if he stops [sex]’, whereas if
sex is hot ‘I will hold on to him’ (Sbongile, 22-year-old trial participant).
The quotes below illustrate the use of the word ‘hot’ to describe sexual desirability:
Snuff brings that heat into your blood [ukushisa kwegazi]. (Zakhona, 31-year-old trial
participant)
Snuff makes you . . . more enjoyable and hot [shisa] during sex. (Nomusa, 33-year-old trial
participant)
Culture, Health & Sexuality 933
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The idea of hot sex was often combined with references to increasing male sex drive
(langazele meaning ‘to long for’ or ‘desire’) or making the woman ‘strong’ during sex in
terms of being physically active during penetration. The words translated as strong included
uqine (‘making strong’), khuthale (‘active’, ‘diligent’ or ‘industrious’) and simame (‘to get
strong’, especially after illness). The word simame is also used to refer to ‘success’ in terms
of someone who is hard working and has elevated their social status.
The following quotes explain the use of intravaginal insertions in terms of increasing
libido:
You may end up experiencing difficulty, maybe your partner is not eager [akasakulangazeleli]
for sex. . . . You insert Zulu things [traditional medicines] in order for your partner to find you
right, so that he is eager [akulangazele] for sex. (Wandile, 33-year-old trial participant)
Some say you must insert, maybe it will help you to be strong [usimame] when you are having
sex. (Bonakele, 46-year-old trial participant)
Snuff was the most commonly reported intravaginal insertion used to achieve ‘hot’ sex.
There are references in the literature to the intravaginal use of snuff by women on their
own for personal sexual satisfaction (Scorgie et al. 2009). Similar reports did emerge in
this investigation, although they were rare.
Tight sex
Increased sexual pleasure was also reported when the woman was ‘tight’. The isiZulu words
to explain this included buyisa: ‘cause to return’ or ‘restore’; qoqa: ‘gather together’ or
‘collect’ generally after being dismantled; buyisana: ‘return’ or ‘become reunited’;
shwaqa: ‘collect together’; or bamba: to ‘grasp’. All these terms referred to bringing the
vagina ‘back together’, implying a return to the ‘natural’ and optimal state of a contracted
and tight vagina. These conditions were regularly described as ‘being like a virgin’
(intombinto meaning ‘young girl who has not been touched’ or itshitshi referring to the age
set of young virgin girls) or not being ‘loose’ (xega). The term loose is viewed as a negative
attribute and is associated with promiscuity and infidelity, as well as older age.
There was another interpretation of being tight, as described by the isiZulu word shuba
(or -shubisa). This means becoming thick in terms of food, literally describing the process of
‘precipitation’ from fluid to solid, for example when jelly sets or milk curdles. Closely
associated is the word qinisa which also means to tighten but more specifically is translated
as to ‘make firm’ or ‘strengthen’. When respondents referred to being ‘wet’, they were
generally referring to the presence of ‘water’ in the vagina. So this idea of ‘thickening’ results
in the transformation of watery secretions into thick mucus. Being tight or thick during sex
was viewed as representing youth, virginity, desirability and being in an optimum state for
the partner’s sexual pleasure. Alum, Blue Stone, Tiger Balm and Disprin were most regularly
associated with tight sex, although Staaldruppels and Entressdruppels were also mentioned:
It is usual [to use insertions] because sometimes you find that you are loose [uyaxega] and you
want to tighten [ezizokuqinisa] yourself. (Gugu, 46-year-old trial participant)
I have heard ladies say that they insert. I do not know whether it is those things that thicken
[bayazishubisa] their vagina. (Thobile, 19-year-old trial participant)
Dry sex
Respondents were far less likely to refer to the use of insertions for vaginal dryness
compared with their ‘hot’ or ‘tight’ attributes. The isiZulu word for ‘dry’ is oma and
934 M. Gafos et al.
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describes becoming dry, being thirsty or the weather being dry such as in a drought. Bad sex
was described as being ‘cold’ and ‘wet’. It would be easy to assume that ‘good’ sex must be
‘hot’ and ‘dry’, but in these interviews there was a distinct meaning to being ‘wet’. Wet was
seen as an unhealthy state for the vagina, generally associated with watery secretions or
STI-related discharge. It was sometimes said that if a woman had been cursed by an evil
spell her vagina would be ‘full of water’. Hence the desire to be dry was often related to the
removal of excessive water or discharge in the vagina and a need to ‘drain the water’:
They insert to become dry [yomile] because maybe a woman feels that she is wet or there
is water [discharge] coming out, then she needs things to insert to make her dry. (Zinhle,
28-year-old trial participant)
None of the references to becoming dry referred to the absence of secretions or abrasive
penetrative sex. Women clearly distinguished between lubrication and excessive wetness
as the following description of good and bad sex demonstrates:
It [good sex] is when sex is slippery [uyashelela] then it is more enjoyable. It’s [bad sex] when
you feel pain . . . . or if you are too wet [umanzi] you do not enjoy sex. (Ntombi, 22-year-old
trial participant)
Microbicide gel
There was an unexpected positive impact of gel use on sexual pleasure. Of the trial
participants and their partners interviewed, 49 of the 63 women and 4 of the 8 men said the
gel enhanced their sexual pleasure. Only one male reported a decrease in sexual pleasure.
The remainder reported that gel did not affect their sexual experience. A number of women
discussed the use of gel in the context of their knowledge of intravaginal insertions:
It has happened for a long time that there are things you insert just for a day and not informing
your partner about such things. Now that there is gel, there is no need to look for other things.
(Cebile, 42-year-old trial participant)
Trial participants said that the gel increased their sexual pleasure by making sex ‘hot’,
‘tight’, ‘smooth’ and ‘dry’. The hot, tight and dry outcomes and the frequency with which
they were reported were consistent with the desired outcome of using intravaginal insertions.
In addition women enjoyed the lubricating effect of the gel which made sex ‘smooth’. The
reports of these experiences did not change across the IDIs at different time points. The
concepts of hot, tight, smooth and dry sex in relation to trial gel use are explored below.
Hot sex
Trial participants were familiar with the idea of both intravaginal insertions and gel
making sex ‘hot’ and at times compared gel use to other women’s use of local insertions:
They say they do it [intravaginal insertion] for them to be alright. Some other things
[insertions] make someone to be alright, others become hot during sex, others become
pleasant during sex . . . I usually tell them that I have got the gel . . . that it makes me to be
alright. (Nonhlanhla, 41-year-old trial participant)
The trial participant quoted below is one of three wives in a polygamous marriage and
states that she has received more attention from her husband than the other wives since she
started using the gel:
It shows there is a difference that the gel makes; he craves that heat [kushisa] that rises, and it
means he can see that it is love that rises, and it’s hot [ukushisa]. (Smisiwe, 54-year-old trial
participant)
Culture, Health & Sexuality 935
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Male partners also referred to the gel making sex hot and increasing women’s libido:
It [gel] makes you feel hot, and makes sex more enjoyable. (Mlungisi, male partner of
39-year-old trial participant)
You see, it happens that if we start having sex, I reach climax and then I sleep. But when my
partner inserts gel, there is encouragement in our lives . . . there is no laziness [during sex].
(Nkosinathi, male partner of 37-year-old trial participant)
Tight sex
References to the trial gel tightening the vagina also reflect how respondents described
intravaginal insertions. As the quote below demonstrates, women often used intravaginal
insertions as a reference point:
What I have noticed with the gel is that when I inserted it, it was like I had used the traditional
herbs [mithi] because it tightened [buyisa] my vagina. . . . It feels tight like that of a child
[itshitshi]. (Jabu, 29-year-old trial participant)
The presence of the gel, which is viscous in consistency, was often described in the
same way as the use of intravaginal insertions, as ‘thickening’ the vaginal secretions. This
woman describes the gel as having a thickening effect, like hair gel:
[Gel] thickens [shubisa] the vagina, I will compare it to the styling gel that is used in hair. . . .
It works perfectly and I think it would help those people who have discharge because it
thickens the vagina. (Khetiwe, 34-year-old trial participant)
In terms of gel use, women used simame to describe the gel being ‘successful’ in
enhancing sexual pleasure thereby having a positive impact on the relationship overall.
Smooth sex
After describing the gel as making sex hot and tight, its lubricating impact was the third
most commonly reported positive attribute. This reference to a preference for ‘slippery’ or
lubricated sex only emerged in relation to gel use, and yet was not divorced from the ideal
of sex being tight or dry. The quotes below highlight the reasons why some women liked
the lubricating effect of the gel:
Eh I can say that after having sex I experienced pains, but since I have been using the gel I have
been okay and sex is not painful. I even felt like after having sex I could have more because it
was not painful, [because] it is slippery. (Ntombi, 22-year-old trial participant)
If I have inserted the gel and by the time we are having sex, he usually feels it being very hot in
a pleasant way and that nice slipperiness. Everything is just nice for him. That is why he would
just say, ‘my darling, insert your thing’ [gel]. (Lungeleni, 26-year-old trial participant)
The desire for lubrication was not universal and the potential lubricating effect of the gel
had caused concern for some participants who ended up being pleasantly surprised that the
gel was not ‘too slippery’:
I was expecting the gel to be slippery [kuyashelela] as it is like Vaseline, but only to find out
that this gel tightens [kuyabamba]. (Nompumelelo, 43-year-old trial participant)
Dry sex
The trial gel is obviously a lubricant, yet the fact that the gel ‘dried’ the vagina was the
fourth most frequently reported positive attribute, after hot, tight and lubricating:
936 M. Gafos et al.
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When I did not use the gel I got wet, but when I used the gel it made me dry. . . . It was more
enjoyable. (Thobile, 19-year-old trial participant)
[Before] there was just water coming out of the vagina, but now that I’m using the gel I feel
alright and dry [ngizomele]. (Senzile, 26-year-old trial participant)
Only one of the eight male partners interviewed commented that he preferred sex
without the gel, because of the increased wetness. He described the gel as being like
‘water’ and stated that a woman using the gel is:
Like a person who is using contraception [injectables], you have one sex act and the next she
is not the same [becomes too wet]. (Siboniso, male partner of 40-year-old trial participant)
Social acceptability
Respondents stated that intravaginal insertions were generally used secretively without the
knowledge of the male partner. The majority of female respondents talked about women
using products for sexual enhancement without expressing either positive or negative
attitudes. However, the majority of all the male respondents viewed the use of insertions
negatively and were suspicious of women who used them. There were a number of
negative connotations associated to the use of intravaginal insertions. These included
assumptions of sexual inadequacy, infidelity and promiscuity if a woman had to use a
product for her or her partner to enjoy sex:
There is my friend, who inserts [intravaginal insertions]. She says that she does that because
she wants to be enjoyed during sex. Maybe her partner told her that she is not great at sex.
(Busisiwe, 23-year-old trial participant)
I have heard people at school saying that snuff is useful when one has been cheating so that the
real partner does not feel that you have been cheating. (Samke, 21-year-old female FGD
participant)
Conversely, over half of the trial participants disclosed gel use to their partners. Gel
use was viewed positively by both women and men, although men from the general
community were adamant that they would want to know if their partner was using the gel.
However, the common belief that men could ‘feel’ if a woman had had sex with someone
else made some men suspicious of the gel. One male partner of a trial participant reported
that the only thing he did not like about the gel was that he could not tell if his partner had
been unfaithful:
I can say if you are having sex with someone there is a difference between if you had sex with
her many days ago or if you had sex with her yesterday. There is a difference that feels like
this person has been having sex with another person. The difference is [when using gel] you
cannot differentiate whether she has been with another person. (Nkule, male partner of
37-year-old trial participant)
One woman was forced to stop using the trial gel due to her partner hearing rumours in a
bar that women were using the gel to hide infidelity.
Sexual pleasure
Although the conversations about the use of intravaginal insertions related to increasing
sexual pleasure, it was often unclear as to whether they were considered to increase the
males’ sexual pleasure or that of the woman. When this topic was probed, it was often
difficult to distinguish between a woman being sexually satisfied versus her being satisfied
that she had sexually satisfied her partner. This discussion was infused with the expectation
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that a woman was supposed to satisfy her partner and failure to do so could result in the
partner taking an additional girlfriend or the complete dissolution of the relationship.
However, the discussion relating to gel use and sexual pleasure was far less ambiguous.
One third of the women who reported that gel increased sexual pleasure claimed that the
increased pleasure was predominantly experienced by the men and another third claimed it
was predominantly experienced by the women. In these discussions there was a far stronger
emphasis on female sexual desire and pleasure. This often related to the lubrication of the
gel reducing pain during sex, as well as increasing sexual stimulation and consequently,
female satisfaction:
I was feeling pain before I used gel, but now because it [gel] softens [lubricates], now I am
enjoying sex as a woman. (Nompilo, 39-year-old trial participant)
Whilst many women reported experiencing pain during sex, it was clear that pain was not a
necessary aspect of sex and was not desired by women. This differs from recent findings in
Mozambique where good sex was expected to be painful and involve friction (Bagnol and
Mariano 2008).
The quotes below also demonstrate the impact that women felt gel use had on their
sexual pleasure:
I enjoy sex because we take longer before we orgasm if we use the gel. (Nobuhle, 28-year-old
trial participant)
It didn’t happen that I lag behind when we are having sex [with gel]. . . . It does happen that
the woman reaches orgasm first, or the partner first, this time since I used your thing [the gel]
it is me who came first like when you reach first and the man later. (Caba, 56-year-old trial
participant)
Discussion
In this paper, we set out to examine whether the use of intravaginal insertions could be in
conflict with the introduction of microbicide gels in a predominantly rural part of KwaZulu-
Natal, South Africa. We have described the types of intravaginal insertions used in the
community and their desired effects. We found that the experience of using trial gels –
which made sex hot, tight and dry – precisely matched the desired outcomes of intravaginal
insertion. Our study provides evidence that vaginal microbicide gels may be more
acceptable in communities where intravaginal insertion is practiced than previously
thought. These findings also support the WHO study in arguing that intravaginal insertions
are not exclusively associated with a desire for dry sex.
There are two reasons why the association between intravaginal insertion and dry sex
may have been previously overstated. Firstly, there has been research into intravaginal
insertion for almost six decades with insertions being reported to tighten, dry and warm
the vagina. However the advent of the HIV epidemic reignited interest in intravaginal
insertion and raised concern about a link between the drying effect of various vaginal
practices and HIV infection (Dallabetta et al. 1995; Fonck et al. 2001; Gresenquet et al.
1997; Mann et al. 1988; Myer et al. 2005, 2006; Runganga and Kasule 1995; van de Wijgert
et al. 2000). Consequently researchers focused on dry sex and often phrased questions
about vaginal practices to explicitly ask about the use of vaginal drying agents.
Secondly, the desire for dry sex is atypical in terms of Western concepts of sexual
pleasure and therefore became a ‘cultural practice of interest’. Conversely, it is not
unusual for women in Western countries to desire a tight vagina (Braun and Kitzinger
2001), evidenced by a growing demand for vaginal laser treatment and cosmetic surgery
to tighten the vagina and vulvar structures. The idea of heat stimulation is also not
938 M. Gafos et al.
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uncommon in Western countries: a well known condom brand markets a heat lubricant,
described as creating ‘a warming sensation that will immediately heighten sensitivity’.
The main strength of this study is our ability to investigate in depth the concept of dry
sex among a cohort of women using lubricant-based vaginal gels. When respondents
discussed the use of insertions to dry the vagina, it might have been assumed that vaginal
secretions were being removed to reduce lubrication and increase friction. However, the
same respondents described the lubricating gel as drying the vagina. The comparison
between traditional intravaginal insertions and the gel has allowed us to critically review
the idea of vaginal ‘dryness’. These trial participants could have been using one of three
vaginal gels: 0.5% PRO2000, 2% PRO2000 or placebo. Consequently it will be important
to evaluate whether reports of the gel drying the vagina, or in fact making sex hot or tight,
differ by gel group in future analyses.
A limitation of this study is that only a minority of the respondents reported using
intravaginal insertions themselves and only the women enrolled in the trial and their male
partners had used the trial gels. This limited our ability to directly compare the experience
of using intravaginal insertions with the use of microbicide gels. In addition, given that the
use of intravaginal insertion was prohibited when using the microbicide trial gels, it is
probable that women who regularly use insertions were discouraged from joining the trial
and possible that women in the trial underreported intravaginal insertion. Finally, in this
paper we focused exclusively on intravaginal insertions. However, intravaginal cleansing,
external application and oral ingestion of products are also associated with increasing
sexual pleasure in KwaZulu-Natal. It will be important to also investigate the desired
effects of these practices in order to evaluate a possible conflict with microbicide gel use.
Our findings also highlight issues that need to be considered before the introduction
of an effective microbicide. There were some reports of negative associations with
intravaginal insertion relating to sexual inadequacy and promiscuity. In this study, trial
participants often explained their use of gel in terms of their knowledge of intravaginal
insertion. Given this cross-fertilisation of language, the potential risk of these limited
negative connotations being transferred to an effective microbicide gel need to be
considered in the development of future microbicide marketing strategies.
A major difference between intravaginal insertion and gel use was the focus on female
sexual pleasure in relation to the gel. This stronger emphasis on female sexual pleasure may
be the result of the gel itself. However, it is important to note that women enrolled in the
microbicide trial were encouraged to talk about their sexual experiences regularly. Therefore,
women enrolled in the trial may have been more forthcoming in discussing sexuality and
pleasure in terms of gel use. These findings do not negate the gender imbalances of sexual
encounters in this population, but they do present an image of female sexual desire and sexual
expectation that has often been absent in discussions about intravaginal insertion.
Women were eager to use a product that could reduce pain and discomfort during sex and
increase sexual pleasure for both themselves and their partners. The trial gel offered both
relief and satisfaction. Local familiarity with the idea of physically inserting products
vaginally appeared to demystify the vaginal insertion of a microbicide gel. In addition, the
discourse surrounding intravaginal insertion provided clear terms of reference for women to
explain their use of a novel vaginal product. This not only counters the fear that microbicide
gels may be less acceptable in communities where intravaginal insertions are used for sexual
enhancement, but suggests that local knowledge, language and understanding of using
products vaginally may actually facilitate the introduction of microbicide gels.
Regardless of whether or not an effective microbicide is eventually formulated in a
lubricant gel or another formulation applied vaginally, marketing strategies will have to
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take account of local perceptions of intravaginal insertion as well as sexual practices,
preferences and expectations. There is evidence to date that microbicide gels are acceptable
among trial cohorts. In this paper we have demonstrated that a desire for dry sex does not
preclude a desire for lubrication. This finding provides optimism regarding the acceptability
of a lubricant-based microbicide in the broader community if a microbicide gel is found to
be effective against HIV.
Acknowledgements
We would like to thank the people of the Umkhanyakude District for their support. We especially
thank all the women and men who participated in the Africa Centre Microbicides Development
Programme feasibility study, pilot study and MDP301 clinical trial. We also thank all the Africa
Centre microbicide study staff for their commitment and dedication. This paper is dedicated to five
staff members who have died since the start of the Africa Centre Microbicide Study: Bonisiwe
Mfekayi, Rachel Gina, Derrick Xulu, Thobile Ndaba and Manini Ngwenya. The MDP301 clinical
trial was sponsored by the UK Medical Research Council (MRC) and funded by the Department for
International Development (DFID) and MRC. The Africa Centre for Health and Population Studies
of the University of KwaZulu-Natal, South Africa, is supported through grants from the Wellcome
Trust (082384/Z/07/Z).
References
Bagnol, B., and E. Mariano. 2008. Vaginal practices: Eroticism and implications for women’s health
and condom use in Mozambique. Culture Health & Sexuality 10, no. 6: 573–85.
Beksinska, M., H.V. Rees, I. Kleinschmidt, and J. McIntyre. 1999. The practice and prevalence of
dry sex among men and women in South Africa: A risk factor for STIs? Sexually Transmitted
Infections 75, no. 3: 178–80.
Beksinska, M., B. Kunene, N. Manzini, F. Scorgie, M. Chersich, and J. Smit. 2008. Prevalence of
vaginal practices in KwaZulu-Natal, South Africa: Results of a household survey [abstract #
CP67-591]. Paper presented at the 5th International Microbicides Conference, June 24–27,
New Delhi, India.
Bentley, M., A. Fullem, E.E. Tolley, C.W. Kelly, N. Jogelkar, N. Srirak, L. Mwafulirwa,
G. Khumalo-Sakutukwa, and D. Celentano. 2004. Acceptability of a microbicide among women
and their partners in a 4-country phase-I trial. American Journal of Public Health 94, no. 7:
1159–64.
Berglund, A.I. 1976. Zulu thought-patterns and symbolism. Bloomington and Indianapolis: Indiana
University Press.
Boyatzis, R.E. 1998. Transforming qualitative information: Thematic analysis and code
development. Newbury Park, CA: Sage.
Braun, V., and C. Kitzinger. 2001. The perfectible vagina: Size matters. Culture, Health & Sexuality
3, no. 3: 263–77.
Braunstein, S., and J. van de Wijgert. 2003. Critical issues in reproductive health. Cultural norms
and behavior regarding vaginal lubrication during sex: Implications for the acceptability of
vaginal microbicides for the prevention of HIV/STIs. New York: Population Council.
Brown, J., O. Ayowa, and R. Brown. 1993. Dry and tight: Sexual practices and potential AIDS risk
in Zaire. Social Science and Medicine 37, no. 8: 989–94.
Brown, J.E., and R.C. Brown. 2000. Traditional intravaginal practices and the heterosexual
transmission of disease: A review. Sexually Transmitted Diseases 27, no. 4: 183–7.
Civic, D., and D. Wilson. 1996. Dry sex in Zimbabwe and implications for condom use. Social
Science and Medicine 42, no. 1: 91–8.
Dallabetta, G.A., P.G. Miotti, J.D. Chiphangwi, G. Liomba, J.K. Canner, and A.J. Saah. 1995.
Traditional vaginal agents: Use and association with HIV infection in Malawian women. AIDS 9,
no. 3: 293–7.
Fonck, K., R. Kaul, F. Keli, J.J. Bwayo, E.N. Ngugi, S. Moses, and M. Temmerman. 2001. Sexually
transmitted infections and vaginal douching in a population of female sex workers in Nairobi,
Kenya. Sexually Transmitted Infections 77, no. 4: 271–5.
940 M. Gafos et al.
D
ow
nl
oa
de
d 
by
 [L
on
do
n S
ch
oo
l o
f H
yg
ien
e &
 T
ro
p M
ed
ici
ne
] a
t 0
8:3
6 1
4 D
ec
em
be
r 2
01
7 
Gresenguet, G., J.K. Kreiss, M.K. Chapko, S.L. Hillier, and N.S. Weiss. 1997. HIV infection and
vaginal douching in Central Africa. AIDS 11, no. 1: 101–6.
Henderson, P.C. 2005. A gift without shortcomings: Healers negotiating the intersection of the local
and global in the context of HIV/AIDS. Social Dynamics 31, no. 2: 24–54.
Hilber, A.M., M.F. Chersich, J.H. van de Wijgert, H. Rees, and M. Temmerman. 2007. Vaginal
practices, microbicides and HIV: What do we need to know? Sexually Transmitted Infections 83,
no. 7: 505–8.
Hilber, A.M., T.H. Hull, E. Preston-Whyte, B. Bagnol, J. Smit, C. Wacharasin, N. Widyantoro,
and WHO GSVP Study Group. 2010. A cross cultural study of vaginal practices and
sexuality: Implications for sexual health. Social Science and Medicine 70, no. 3: 392–400.
Jolles, F., and S. Jolles. 2000. Zulu ritual immunisation in perspective. Africa: Journal of the
International African Institute 70, no. 2: 229–48.
Karim, Q.A., S.S. Karim, K. Soldan, and M. Zondi. 1995. Reducing the risk of HIV infection among
South African sex workers: Socio-economic and gender barriers. American Journal of Public
Health 85, no. 11: 1521–5.
Kun, K. 1998. Vaginal drying agents and HIV transmission. International Family Planning
Perspectives 24, no. 2: 93–4.
Mann, J.M., N. Nzilambi, P. Piot, N. Bosenge, M. Kalala, H. Francis, R.C. Colebunders, P.K. Azila,
J.W. Curran, and T.C. Quinn. 1988. HIV infection and associated risk factors in female
prostitutes in Kinshasa, Zaire. AIDS 2, no. 4: 249–54.
Montgomery, C.M., M. Gafos, S. Lees, N.S. Morar, O. Mweemba, A. Ssali, J. Stadler, R. Pool, and
the MDP team. 2010. Re-framing microbicide acceptability: Findings from the MDP 301 trial.
Culture, Health & Sexuality 12, no. 6: 649–62.
Morar, N.S., and G. Ramjee. 1997. ‘Dry sex’ and douching practices among sex workers at truck
stops in KwaZulu-Natal. Health Systems Trust Update 27: 5–6.
Morar, N.S., G. Ramjee, and S.S. Karim. 1998. Vaginal insertion and douching practices among sex
workers at truck stops in KwaZulu-Natal. South African Medical Journal 88, no. 4: 470.
Morrow, K., R. Rosen, L. Richter, A. Emans, A. Forbes, J. Day, N. Morar, L. Maslankowski,
A.T. Profy, C. Kelly, S.S. Abdool Karim, and K.H. Mayer. 2003. The acceptability of an
investigational vaginal microbicide, PRO2000 gel, among women in a phase-I clinical trial.
Journal of Women’s Health 12, no. 7: 655–66.
Myer, L., L. Kuhn, Z.A. Stein, T.C. Wright, and L. Denny. 2005. Intravaginal practices, bacterial
vaginosis, and women’s susceptibility to HIV infection: Epidemiological evidence and
biological mechanisms. Lancet Infectious Diseases 5, no. 12: 786–94.
Myer, L., L. Denny, M. de Souza, T.C. Wright, and L. Kuhn. 2006. Distinguishing the temporal
association between women’s intravaginal practices and risk of HIV infection: A prospective
study of South African women. American Journal of Epidemiology 163, no. 6: 552–60.
Nunn, A., S. McCormack, A.M. Crook, R. Pool, C. Rutterford, and R. Hayes. 2009. Microbicides
Development Programme: Design of a phase-III trial to measure the efficacy of the vaginal
microbicide PRO 2000/5 for HIV prevention. Trials 10, no. 99: DOI:10.1186/1745-6215-10-99.
Ramjee, G., N.S. Morar, S. Braunstein, B. Friedland, H. Jones, and J. van de Wijgert. 2007.
Acceptability of Carraguard, a candidate microbicide and methyl cellulose placebo vaginal gels
among HIV-positive women and men in Durban, South Africa. AIDS Research and Therapy 4,
no. 20: DOI: 10.1186/1742-6405-4-20.
Runganga, A.O., and J. Kasule. 1995. The vaginal use of herbs/substances: An HIV transmission
facilitatory factor? AIDS Care 7, no. 5: 639–45.
Runganga, A., M. Pitts, and J. McMaster. 1992. The use of herbal and other agents to enhance sexual
experience. Social Science and Medicine 35, no. 8: 1037–42.
Sandala, L., P. Lurie, M.R. Sunkutu, E.M. Chani, E.S. Hudes, and N. Hearst. 1995. ‘Dry sex’ and
HIV infection among women attending a STD clinic in Lusaka, Zambia. AIDS 9, suppl. 1:
S61–S68.
Scorgie, F., B. Kunene, J.A. Smit, N. Manzini, M.F. Chersich, and E.M. Preston-Whyte. 2009.
In search of sexual pleasure and fidelity: Vaginal practices in KwaZulu-Natal, South Africa.
Culture, Health & Sexuality 11, no. 3: 267–83.
Tanser, F., V. Hosegood, T. Ba¨rnighausen, M. Nyirenda, W. Muhwava, C. Newell, J. Viljoen,
T. Mutevedzi, and M.L. Newell. 2008. Cohort profile: Africa Centre Demographic Information
System (ACDIS) and population-based HIV survey. International Journal of Epidemiology 37,
no. 5: 956–62.
Culture, Health & Sexuality 941
D
ow
nl
oa
de
d 
by
 [L
on
do
n S
ch
oo
l o
f H
yg
ien
e &
 T
ro
p M
ed
ici
ne
] a
t 0
8:3
6 1
4 D
ec
em
be
r 2
01
7 
Vandebosch, A., E. Goetghebeur, G. Ramjee, M. Alary, V. Ettie`gne-Traore´, V. Chandeying, and
L. Van Damme. 2004. Acceptability of COL-1492, a vaginal gel, among sex workers in one
Asian and three African cities. Sexually Transmitted Infections 80, no. 3: 241–3.
Wijgert, J.H. van de, P.R. Mason, L. Gwanzura, M.T. Mbizo, Z.M. Chirenje, V. Iliff, S. Shiboski,
and N.S. Padian. 2000. Intravaginal practices, vaginal flora disturbances and acquisition of
sexually transmitted diseases in Zimbabwean women. Journal of Infectious Diseases 181, no. 2:
587–94.
Woodsong, C., and P. Alleman. 2008. Sexual pleasure, gender power and microbicide acceptability
in Zimbabwe and Malawi. AIDS Education and Prevention 20, no. 2: 171–87.
World Health Organization (WHO). 2007. Harmful practices: Multi-country study on gender,
sexuality and vaginal practices. Preliminary reports and findings. WHO. http://www.who.int/
reproductivehealth/topics/fgm/other_harmful_practices/en/
Re´sume´
L’insertion intra-vaginale est souvent associe´e au concept de sexe “sec”. A´ ce jour, tous les
microbicides teste´s dans le but de pre´venir l’infection a` VIH sont des gels contenant du lubrifiant,
qu’il faut appliquer dans le vagin. Dans cet article, nous examinons les possibles contradictions entre
les pratiques d’insertion intra-vaginale et celles de l’insertion vaginale de gels microbicides. Le site
Africa Centre e´tait inclus dans le programme de de´veloppement des microbicides e´valuant le gel
microbicide PRO2000/5. Nous avons conduit des entretiens en profondeur et des groupes de
discussion the´matiques avec des femmes participant a` cet essai, ainsi que des femmes et des hommes
issus de la communaute´. L’analyse s’est concentre´e sur les connaissances des individus sur
l’insertion intra-vaginale pratique´e dans la communaute´ et sur l’expe´rience des gels e´tudie´s chez les
participantes. Le recours a` l’insertion intra-vaginale de diffe´rents produits s’est re´ve´le´ largement
reconnu. Nous avons de´couvert que l’expe´rience des gels a` l’e´tude, qui rendent le sexe «chaud»,
«serre´» et «sec» allait de pair avec les conse´quences attendues de l’insertion intra-vaginale. Nous
avons de´couvert que par «se´cheresse vaginale», il fallait entendre la suppression de l’exce`s de
se´cre´tions inhabituelles, plutoˆt que celui des se´cre´tions vaginales normales, et que l’insertion intra-
vaginale n’est pas exclusivement associe´e au de´sir de sexe «sec». Les re´sultats de l’e´tude apportent
la preuve que les gels microbicides vaginaux peuvent eˆtre plus acceptables qu’on ne le pensait
auparavant dans des communaute´s au sein desquelles l’insertion vaginale est pratique´e.
Resumen
La insercio´n intravaginal suele asociarse con el concepto de sexo ‘seco’. Todos los microbicidas para
prevenir el contagio del VIH probados hasta la fecha han sido geles de lubricantes que se aplican en
la vagina. En este artı´culo, examinamos si el uso de inserciones intravaginales podrı´a entrar en
conflicto con la introduccio´n de geles de microbicidas vaginales. El Africa Centre participo´ en el
Programa de Desarrollo de Microbicidas para evaluar el gel microbicida PRO2000/5. Llevamos a
cabo entrevistas exhaustivas y charlas con grupos de mujeres que participaron en el ensayo ası´ como
de mujeres y hombres de la comunidad. En el estudio se analizo´ en concreto que´ nivel de
conocimientos tenı´an las personas de la comunidad del uso de la insercio´n intravaginal y que´
experiencias tenı´an los participantes del estudio con el uso de los geles del ensayo. Los participantes
conocı´an bastante bien el uso intravaginal de toda una amplia variedad de productos. Observamos
que la experiencia de usar los geles del ensayo – que causaba que el sexo fuese ‘caliente’, ‘estrecho’
y ‘seco’ – coincidı´a con los resultados deseados de la insercio´n intravaginal. Descubrimos que
cuando los participantes describı´an la sequedad de la vagina se referı´an a la eliminacio´n de
cantidades excesivas de fluidos inusuales ma´s que a la eliminacio´n de las secreciones vaginales
normales y que la insercio´n intravaginal no se asociaba exclusivamente al deseo de tener relaciones
sexuales ‘secas’. Los resultados del estudio ofrecen evidencias de que los geles de microbicidas
vaginales podrı´an ser ma´s aceptados de lo que se pensaba en las comunidades donde la insercio´n
intravaginal es una pra´ctica habitual.
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